Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness

NCT06254560 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Severe Aplastic Anemia
Platelet Transfusion Refractoriness

Interventions

DRUG: Rituximab

Sponsor

Institute of Hematology & Blood Diseases Hospital, China